GALNT6 was shown to promote metastasis of breast cancer cells by enhancing mucin-type O-glycosylation, and α2M was identified as a novel substrate of GALNT6 in the secretory supernatant of breast cancer cells. Here, A2M is linked to breast carcinoma.